Request Current Tyloxapol Price and Availability

Tyloxapol Applications

Some relevant literature;

Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles. Van Lengerich, Bernhard H. (General Mills, Inc., USA). PCT Int. Application (2000), 56 pp. WO 2000021504

Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum. AJ Ghio, BC Marshall, JL Diaz, T Hasegawa, W Samuelson, D Povia, TP Kennedy and CA Piantodosi. Am. J. Respir. Crit. Care Med., Vol 154, No. 3, Sep 1996, 783-788.

Polymeric surfactants for enhanced oil recovery. Part III. Interfacial tension features of ethoxylated alkylphenol-formaldehyde nonionic surfactants. Barakat, Y.; Basily, I. K.; Mohamad, A. I.; Youssef, A. M. British Polymer Journal (1989), 21(6), 459-65

Use of PEG-derivatized lipids as surface stabilizers for nanoparticulate compositions. Liversidge, Elaine; Gottardy, Greta A. (Nanosystems, USA). PCT Int. Application (2000), 41 pp. WO 2000051572

Method for the production of porous particles. Chattopadhyay, Pratibhash; Shekunov, Boris Y.; Gibson, Adam K. (Ferro Corporation, USA). U.S. Pat. Application Pub (2007), 8pp. US 2007275076

If you would like to receive current pricing, please complete the form below: